To elucidate the molecular mechanisms responsible for elevated m6A levels in pancreatic cancer, we assessed the expression of the most important m6A regulatory factors (METTL3, METTL14, and WTAP, which form a complex) in the paired cancer and adjacent tissue samples. This evidence concerns the gene METTL3 and pancreatic neoplasm.